Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the diabetic retinopathy market right now?

The market size for diabetic retinopathy has seen a robust growth lately and is forecasted to expand from $8.61 billion in 2024 to an estimated $9.29 billion in 2025. The growth represents a compound annual growth rate (CAGR) of 7.9%. The surge in the past period is largely due to factors such as the aging demographic, a rise in diabetes cases, enhanced understanding regarding diabetic retinopathy, upgrading of healthcare facilities, and increased spending on healthcare.

How fast Is the diabetic retinopathy market expected to grow, and what’s its future value?

In the upcoming years, a substantial expansion in the diabetic retinopathy market is forecasted, with the market predicted to reach $12.56 billion in 2029 following a compound annual growth rate (CAGR) of 7.8%. Factors driving this projected growth over the forecasted period encompass the rise of personalized medicine, the broadening scope of telemedicine services, the creation of innovative therapeutic treatments, the adoption of point-of-care testing, and the implementation of remote patient monitoring. Foreseen trends throughout this timeframe include the application of precision medicine in the treatment of diabetic retinopathy, an enhanced emphasis on early detection and prevention, growth of teleophthalmology services, an uptick in gene therapy research, and continuous progress in retinal imaging technology.

Get your diabetic retinopathy market report here!

https://www.thebusinessresearchcompany.com/report/diabetic-retinopathy-global-market-report

What are the leading drivers of growth in the diabetic retinopathy market?

The escalating incidences of diabetes are projected to fuel the expansion of the diabetic retinopathy market in upcoming times. Diabetes is a long-standing metabolic disorder leading to increased glucose levels in the blood. Factors like obesity, genetic predisposition, and lack of physical activity contribute to diabetes progression. Moreover, individuals with this condition have an excess amount of sugar in their blood that can harm the retina – an integral part of the eye responsible for light detection and signal transmission to the brain via a nerve at the back of the eye. As an illustration, the Office for Health Improvement and Disparities, a UK governmental agency, reported in March 2024 that between March 2022 and March 2023, the percent of persona with type 1 diabetes obtaining all eight recommended health checks saw a 22% rise, while for type 2 diabetes, there was a 21% increase. Additionally, the portion of people accomplishing targeted HbA1c levels hit 37.9% – the highest mark ever noted by the National Diabetes Audit. In conclusion, the increasing prevalence of diabetes is a key factor propelling the growth of the diabetic retinopathy market.

What are the key segments defining the diabetic retinopathy market?

The diabetic retinopathy market covered in this report is segmented –

1) By Type: Proliferative Diabetic Retinopathy, Non-Proliferative Diabetic Retinopathy

2) By Treatment: Anti-VEGF Drugs, Intraocular Steroid Injection, Laser Photocoagulation, Vitreoretinal Surgery

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Proliferative Diabetic Retinopathy (PDR): Neovascularization, Vitreous Hemorrhage, Tractional Retinal Detachment

2) By Non-Proliferative Diabetic Retinopathy (NPDR): Mild NPDR, Moderate NPDR, Severe NPDR

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12187&type=smp

Who are the key players steering the development of the diabetic retinopathy market?

Major companies operating in the diabetic retinopathy market include Pfizer Inc., F-Hoffmann-La Roche Ltd., Abbvie Inc., Bayer AG, Novartis AG, Ellex Medical Lasers Ltd., Abbott Laboratories Inc., Regeneron Pharmaceuticals Inc., Bausch Health Companies Inc., Icon Bioscience Inc., Allergan plc., Genentech Inc., Aurobindo Pharma, Santen Pharmaceutical Co. Ltd., Carl Zeiss Meditec AG, Valeant Pharmaceuticals International Inc., Lumenis Ltd., Optos Plc., Quantel Medical SAS, NIDEK Co. Ltd., IRIDEX Corporation, Alimera Science Inc., Kowa Company Ltd., Ocular Therapeutix Inc., Aerpio Pharmaceuticals Inc., Kodiak Sciences Inc., Oxurion NV, Graybug Vision Inc., Ampio Pharmaceuticals Inc.

What emerging trends are influencing the growth of the diabetic retinopathy market?

The progress in technology is a prominent growing trend in the diabetic retinopathy market. To maintain their competitive edge, key players in the large volume parenteral market are integrating new technological solutions. For instance, Baxter International Inc., a healthcare firm based in the US, introduced the Welch Allyn RetinaVue 100 Imager PRO in South Korea in July 2022. Such innovations aim to aid in the identification of diabetic retinopathy in primary healthcare environments. RetinaVue has demonstrated its effectiveness in enhancing patient adherence to vital annual diabetic retinal exams (DREs) by enabling quick and convenient screenings during regular primary care appointments.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12187

Which regions are most influential in expanding the diabetic retinopathy market?

North America was the largest region in the diabetic retinopathy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diabetic retinopathy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Autonomous Ships Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/autonomous-ships-global-market-report

Ship Building And Repairing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ship-building-and-repairing-global-market-report

Cranes Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cranes-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: